Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by gebremeskelon Jul 19, 2018 1:13pm

101 Views

Post# 28339562

RE:RE:Patent expiration

RE:Shareholder expiration

I hope I'm still on my feet then too. I'll be in my 80's.....

vestor111 wrote: Patents in Pharma are quite often extended decades by a rolling series of new claims about the patent. But 2034 should more than see the company on to its feet and beyond.

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta